aTyr Pharma, Inc. (LIFE) Financials
LIFE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 122.1 million | 31.6 million |
2023-09-30 | 125.1 million | 26.9 million |
2023-06-30 | 132.7 million | 26.7 million |
2023-03-31 | 136.8 million | 27.1 million |
LIFE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -11.1 million | 659000 |
2023-09-30 | -10.1 million | 664000 |
2023-06-30 | -14.4 million | 658000 |
2023-03-31 | -1.8 million | 619000 |
LIFE Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -14.8 million |
2023-09-30 | -11.3 million |
2023-06-30 | -12.3 million |
2023-03-31 | -12.0 million |
LIFE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 98.2 million | - | 15.1 million |
2023-09-30 | 105.6 million | - | 15.2 million |
2023-06-30 | 108.6 million | - | 15.4 million |
2023-03-31 | 114.4 million | - | 14.3 million |
LIFE Shares Outstanding
LIFE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 17000 | 12.8 million | 3.2 million | -407000 |
2023-09-30 | 557000 | 10.3 million | 2.6 million | - |
2023-06-30 | 2.4 million | 9.8 million | 3.7 million | - |
2023-03-31 | 1.2 million | 9.4 million | 3.4 million | - |
LIFE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 407000 |
2023-09-30 | 353000 | 993000 |
2023-06-30 | - | 586000 |
2023-03-31 | - | 755000 |
LIFE
Price: $1.70
52 week price:
Earnings Per Share: -0.94 USD
P/E Ratio: -1.77
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 171300
Ebitda: -10.7 millionMarket Capitalization: 113.8 million